ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Long queues in Pakistan to buy Sputnik V as commercial sales begin

Karachi [Pakistan], April 6 (ANI): Thousands of Pakistanis rushed to COVID-19 vaccination sites to get inoculated in the first round of commercial sales of Sputnik V vaccines.  

ANI Apr 06, 2021 14:15 IST googleads

Representative Image

Karachi [Pakistan], April 6 (ANI): Thousands of Pakistanis rushed to COVID-19 vaccination sites to get inoculated in the first round of commercial sales of Sputnik V vaccines.

The commercial sales of Sputnik V began over the weekend, with vaccination sites in the southern city of Karachi saying they had already sold out, reported TRTWorld.

Pictures of queues outside the hospital late into the night were shared on social media.

Pakistan is currently offering free vaccines to frontline healthcare workers and people over the age of 50, but the drive has thus far been slow, and last month the country allowed commercial imports by the private sector for the general public.

Those still not eligible for the government's free vaccination wait in long queues at vaccination sites in Pakistan to get vaccinated despite the USD 80 (12,000 Pakistani rupees) cost for a pack of two doses as the country allows private sales of the Covid-19 vaccines.

Despite the cost, a number of centres offering the shot reported long queues, with some in Karachi waiting in line for close to three hours. Most in the queue were young Pakistanis still not eligible for the government's free vaccination, reported TRTWorld.

While the private sale of vaccines has begun, the government and importers are still locked in a pricing dispute.

Pakistan initially agreed to exempt imported vaccines from price caps, but later rescinded the exemption and said it would set maximum prices.

One pharmaceutical company, which had already imported 50,000 doses of Sputnik V, took the government to court, where it won an interim order allowing it to sell it until pricing is decided, reported TRTWorld.

The number of patients now in critical care has reached 3,568, the highest since the pandemic started, a cabinet minister, Asad Umar, said on Twitter.

Pakistan has thus far reported 687,908 infections and 14,778 deaths, reported TRTWorld. (ANI)

Get the App

What to Read Next

Asia

India consistently supported Maldives in crisis: Mohamed Nasheed

India consistently supported Maldives in crisis: Mohamed Nasheed

He highlighted India's role as a "first responder" for the Maldives, emphasising that India's support during critical periods has been fundamental to the stability and security of the island nation.

Read More
Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.